A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients
Titel:
A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients
Auteur:
Sauter, Craig S. Barker, Juliet N. Lechner, Lauren Zheng, Junting Devlin, Sean M. Papadopoulos, Esperanza B. Perales, Miguel-Angel Jakubowski, Ann A. Goldberg, Jenna D. Koehne, Guenther Ceberio, Izaskun Giralt, Sergio Zelenetz, Andrew D. Moskowitz, Craig H. Castro-Malaspina, Hugo
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 20 (2014) nr. 3 pagina's 7 p.
Jaar:
2014
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation